Rachna Khosla - Sep 13, 2021 Form 3 Insider Report for AMGEN INC (AMGN)

Role
SVP, Business Development
Signature
/s/ Rachna Khosla
Stock symbol
AMGN
Transactions as of
Sep 13, 2021
Transactions value $
$0
Form type
3
Date filed
9/13/2021, 07:28 PM
Next filing
Nov 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding AMGN Common Stock 4.07 K Sep 13, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AMGN Nqso (Right to Buy) Sep 13, 2021 Common Stock 1.25 K $162.60 Direct F3
holding AMGN Nqso (Right to Buy) Sep 13, 2021 Common Stock 1.52 K $177.46 Direct F4
holding AMGN Nqso (Right to Buy) Sep 13, 2021 Common Stock 3.64 K $177.31 Direct F5
holding AMGN Nqso (Right to Buy) Sep 13, 2021 Common Stock 2.52 K $236.36 Direct F6
holding AMGN Nqso (Right to Buy) Sep 13, 2021 Common Stock 3.26 K $239.64 Direct F7

Explanation of Responses:

Id Content
F1 These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Equity Incentive Plan: 67 RSUs which will vest on 4/27/2022; 554 RSUs which will vest on 7/31/2022; 280 RSUs which vest in installments of 138 on 5/3/2022 and 142 on 5/3/2023; 300 RSUs which vest in two installments of 99 on 5/5/2022 and 5/5/2023 and one installment of 102 on 5/5/2024; and 375 RSUs which vest in installments of 123 on 4/30/2023, 124 on 4/30/2024 and 128 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 90 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3 1,252 of these non-qualified stock options have vested and are exercisable.
F4 1,001 of these non-qualified stock options have vested and are exercisable and 517 of these options will vest and become exercisable on 4/27/2022.
F5 1,201 of these non-qualified stock options have vested and are exercisable and the remaining options will vest and become exercisable in installments of 1,202 on 5/3/2022 and 1,239 on 5/3/2023.
F6 These non-qualified stock options will vest and become exercisable in three installments of 829 on 5/5/2022, 830 on 5/5/2023 and 856 on 5/5/2024.
F7 These non-qualified stock options will vest and become exercisable in three installments of 1,075 on 4/30/2023, 1,076 on 4/30/2024 and 1,109 on 4/30/2025.